Emagine Solutions Technology Wins ACA Grant, Announces Open Application for Groundbreaking Arizona Maternal Health Study

Pregnant Arizona-based women can sign up to join the study for a chance to receive free maternal health technology

TUCSON, Ariz.--(BUSINESS WIRE)--Emagine Solutions Technology today announced that the Arizona Commerce Authority (ACA) has awarded the maternal health innovator a coveted $250,000 grant through its WearTech Applied Research Center.

With a focus on de-risking investment in future-of-health, biomedical, and other technologies, the WearTech Applied Research Center has supported countless projects since its inception in 2019, in partnership with Arizona universities. The funds will allow Emagine and its partners at The Preeclampsia Foundation to conduct vital research into the impact of technology and wearable devices on pregnancy health.

Emagine seeks applicants for groundbreaking maternal health study

Emagine is now seeking participants for its maternal health technology study. Conducted alongside Dr. Sharon Thompson, OBGYN – Science and Tech Advisor for Emagine – the research will leverage The Journey Pregnancy app and Preeclampsia Foundation Cuff Kits to assess the experiences of Arizona women using wearable devices to monitor their pregnancy health.

Patients must be 18 or older, live in Arizona, and currently pregnant.

Participants will receive:

• A $50 gift card upon study completion
• A free Preeclampsia Foundation blood pressure monitoring kit that includes an iHealth blood pressure monitor
• A free Fitbit Charge 6 Premium Fitness Tracker

Research areas include:

• Exploring participant-reported experiences with health tracking during pregnancy and early postpartum
• Assessing the feasibility of using a home blood pressure cuff, a Fitbit wearable device, and The Journey Pregnancy App during pregnancy

“According to The Commonwealth Fund, our state ranks 44 out of 51 in the country for maternal outcomes, so we believe there is an opportunity to make an impact through this project,” says Emagine Solutions Technology Co-founder and CEO Courtney Williams. “Hypertension in particular is a critical area to study, as women who experience a condition like preeclampsia are 3 to 4 times more likely to have heart issues later on in life. Ultimately, the more feedback and data we can gather, the better we can understand how to use technology to make pregnancy care safer, lower cost, and improve outcomes.”

Those interested in participating in Emagine’s maternal health study just need to complete the eligibility form: https://emaginest.short.gy/WARMMStudy

About Emagine Solutions Technology

An award-winning healthcare technology company, Emagine is your companion for a safe pregnancy. We are tackling the U.S. maternal health crisis with AI-driven remote patient monitoring software for better outcomes. To find out more, visit emaginest.com and follow Emagine on Instagram, Twitter, TikTok and Facebook.